SCHEMBL6181441

SCHEMBL6181441

COC(=O)c1cc(CCN(C)C)ncc1Cl

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.44
PLA2G2A P14555 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NQO2 P16083 2/20 0.38
MELK Q14680 2/20 0.36
MAPT P10636 2/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6181289 0.83 P2RX7 (0.43) P2RX7ALDH1A1KDM4EMELKMAPT
SCHEMBL24769678 0.81 ALDH1A1 (0.43) PLA2G2AALDH1A1TSHRKDM4EGAA
SCHEMBL30017097 0.81 ALDH1A1 (0.40) P2RX7PLA2G2AALDH1A1TSHRKDM4E
SCHEMBL24770163 0.81 ALDH1A1 (0.40) P2RX7PLA2G2AALDH1A1TSHRKDM4E
SCHEMBL4918571 0.80 CYP4F2 (0.39) PLA2G2AALDH1A1TSHRKDM4EGAA
SCHEMBL4750181 0.76 GAA (0.42) ALDH1A1TSHRKDM4EGAAMEN1
SCHEMBL30217866 0.74 KDM4E (0.47) ALDH1A1TSHRKDM4EGAAMEN1
SCHEMBL236107 0.74 KDM4E (0.47) ALDH1A1TSHRKDM4EGAAMEN1
SCHEMBL31133002 0.73 MRGPRX4 (0.36) PLA2G2AALDH1A1TSHRGAAMEN1
SCHEMBL14966057 0.73 PTGES (0.39) PLA2G2AALDH1A1TSHRKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501805-A1 SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2005-02-02 EP disclosed
WO-2003095430-A1 SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-11-20 WO disclosed